Real-time enrollment status for this age-related macular degeneration clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:37 PM UTC
| NCT Number | NCT03178149 |
| Recruiting Status | Recruiting |
| Condition | Age-Related Macular Degeneration |
| Phase | PHASE1 |
| Target Enrollment | 42 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Astellas Institute for Regenerative Medicine |
| Last Updated on CT.gov | September 3, 2026 (Sep 3, 2026) |
As of October 12, 2026: Clinical trial NCT03178149 is currently recruiting participants. This phase1 study for age-related macular degeneration is actively seeking new participants at 20 locations across the United States. The study is sponsored by Astellas Institute for Regenerative Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03178149 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03178149 was last updated Sep 3, 2026 (September 3, 2026). HelloStudys verifies this status automatically.